CM 2-3

opioid receptor antagonist; methylamino group psi-bonded to proline group; RN from Toxlit; casomorphin analog

Also Known As:

TPCH2NHPPG; Tyr-Pro-psi(CH2-NH)-Phe-Pro-Gly; Tyr-Pro-psi(CH2NH)Phe-Pro-Gly; tyrosyl-prolyl-psi(methylamino)-phenylalanyl-prolyl-glycine; tyrosyl-prolyl-psi(methylamino)phenylalanyl-prolyl-glycine

Networked: 24 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Nerve Tissue Proteins: 2
    - Neuropeptides: 6772
      - Opioid Peptides: 1339
        Endorphins: 977
        CM 2-3: 24
- Peptides: 82426
  - Neuropeptides: 6772
    - Opioid Peptides: 1339
      - Endorphins: 977
        CM 2-3: 24

Experts

1.	Jeong, Yujin: 1 article (01/2022)
2.	Jin, Young-Joo: 1 article (01/2022)
3.	Kim, Sang Gyune: 1 article (01/2022)
4.	Kim, Young Seok: 1 article (01/2022)
5.	Kwon, Jung Hyun: 1 article (01/2022)
6.	Kwon, Oh Sang: 1 article (01/2022)
7.	Lee, Jin-Woo: 1 article (01/2022)
8.	Lee, Jungnam: 1 article (01/2022)
9.	Nahm, Soon Woo: 1 article (01/2022)
10.	Shin, Seung Kak: 1 article (01/2022)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2021 - "Receiver operating characteristic (ROC) curve analysis showed that AFP had inadequate accuracy to discriminate survivors and deceased patients in subgroups of patients with tumor size ≤3 cm, 2-3 cm, or ≤2 cm (area under the ROC curve = 0.449, 0.458, 0.443; 95% confidence interval = 0.366-0.533, 0.346-0.571, 0.317-0.569, respectively). " 01/01/2019 - "Kaplan-Meier method, Cox proportional hazards model were used to calculate cancer specific mortality (CSM) and overall mortality (OM) in the unmatched and matched cohort, and in subgroups based on tumour size (< 2 cm, 2-3 cm, 3-4 cm). " 11/01/2013 - "Continuous pathologic tumor size was: (1) largest dimension of largest tumor (cm); (2) tumor area (cm(2)); (3) volume of tumor (cm(3)); (4) with MC/MF disease, summation of (1)-(3) for up to 3 foci. " 01/01/2010 - "Tumor sizes ranged from 8.4 to 20 cm 2/3 were located in the upper stomach. " 10/01/2008 - "(2) Independent testing of expanded criteria, where published data are largely limited to the proposed University of California, San Francisco criteria (1 lesion <or= 6.5 cm, 2-3 lesions each <or= 4.5 cm with total tumor diameter <or= 8 cm). "
2.	Fibrosis (Cirrhosis) 01/01/2022 - "Survival was compared according to the tumor size (≤2 cm/2-3 cm) and the presence of cirrhosis. " 11/01/2000 - "3. Features of HCC in patients with cirrhosis that are associated with a 5-year survival rate of 75% after liver transplantation include (1) solitary tumor less than 5 cm; (2) 3 or fewer tumors, each less than 3 cm; and (3) absence of vascular invasion. "
3.	Pathologic Constriction (Stenosis) 08/01/2019 - "The mean stricture length was 2.5 cm (2-3). " 05/01/2009 - "The occurrence of restricture after incisional therapy was statistically more prevalent in long-segment stricture (>1 cm) (2/3 [66.7%]) than short-segment stricture (<1 cm) (1/21 [4.8%]) (P = .032). "
4.	AIDS-Related Complex (ARC) 09/01/2003 - "The teeth were randomly divided into eight experimental groups: two resin composites (Z250 Charisma) and four polymerization modes (conventional-680 mW/cm2/30 seconds; soft start-380mW/cm2/10 seconds + 680 mW/cm2/20 seconds; plasma arc curing- 1480mW/cm(2)-3 seconds; combined- 380mW/cm2-10 seconds + 1480mW/cm(2)-3 seconds). " 01/01/2005 - "The composite resins were bulk-inserted and polymerized using different light-curing units and times: conventional QTH (quartz-tungsten-halogen; 700 mW/cm(2); 20 s, 30 s and 40 s); LED (light-emitting diode; 440 mW/cm(2); 20 s, 30 s and 40 s); PAC (xenon plasma arc; 1700 mW/cm(2); 3 s, 4.5 s and 6 s). "
5.	Colorectal Neoplasms (Colorectal Cancer) 03/01/1999 - "In the case of liver metastases from colorectal cancer or endocrine tumors, which seem more sensitive to locoregional therapies, complete response rates are not adequate yet being 86%, 26%, 11% and 0% respectively in the case of < 2 cm, 2-3 cm, 3-4 cm and > 4 cm lesions and moreover no definitive data are available about long-term prognosis. "

Related Drugs and Biologics

1.	Tacrolimus (Prograf)
2.	Xenon
3.	Tungsten
4.	Quartz
5.	Ointments (Pastes)
6.	Iodine
7.	Halogens
8.	Composite Resins
9.	Verteporfin (Visudyne)
10.	pimecrolimus (Elidel)

Related Therapies and Procedures

1.	Therapeutics
2.	Lasers (Laser)
3.	Optical Fibers
4.	Liver Transplantation
5.	Nephrectomy